Nachrichten

06 Oktober 2021
Baylis Medical Company Inc. is pleased to announce it has reached an agreement to sell its cardiology business to Boston Scientific Corporation.
Press Release
03 August 2021
The company is establishing a manufacturing plant in La Lima Free Zone, in Cartago, where it will manufacture cardiovascular products to serve global markets.
Press Release
05 Mai 2021
Baylis Medical is proud to announce that it is a Gold Standard Winner of the Canada’s Best Managed Companies award.
Press Release
19 Januar 2021
Baylis Medical gab heute die Markteinführung und den ersten klinischen Fall des JLL 2-French-Elektrophysiologie-Mikrokatheters in Europa bekannt.
Press Release
01 September 2020
Baylis Medical announced today the first clinical use of the VersaCross Steerable Access Solution, performed at the University of California, San Francisco (UCSF).
Press Release
07 Juli 2020
Baylis Medical, a Canadian medical device company specializing in cardiology and spine, is pleased to announce that it has made a venture arm investment in Epineuron Technologies Inc., a bioelectronic medical company that provides therapy to support patients with peripheral nerve regeneration.
Press Release

Medien Kontakt

media@baylismedical.com